Thalidomide Paradoxical Effect on Concomitant Multiple Myeloma and Myelodysplasia

References

• Leone.Pulsoni. A., Equitani. F. and Pagano. L. (1999) "The incidence of secondary leukemias", Haenueologica 84, 937–945.
   PubMed Web of Science ®Google Scholar
• Govindrtrajan, R.. Jagannath, S., Flick. IT., Vesole, D.H.. Sawyer, J.. BitrIogie. B. and Tricot. G. (1996) "Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma", Brr. J. Haenrotol. 95, 349–353.
   Google Scholar
• Soenen, V., Preudhomme, C., Roomier. C.. Lai, J.L., Lepelley, P., Facon, T., Pagniez. D. and Fenaux. P. (1998) "Myelodysplasia during the course of myeloma. Restriction of 1p deletion and p53 over-expression to myeloid cells". Leirkernio 12. 238–241
   Google Scholar
• Wiernik, PH. (1996) "Leukemias and myeloma". Cancer Chernother. Biol. Response Mink! 16, 347–375.
   Google Scholar
• Dunning. K. (1999) "Undemanding MDS". Rehabil Manag. 12. 36–39.
   PubMedGoogle Scholar
• Hofmann. W.K. Ganser. A. and Hoelzer. D. (1996) "Myelodys-plastic syndromes: clinical features", $emin_ !Mauna 33, 177–185.
   Google Scholar
• Drach, J., Ayers. D., Govindaralan. R., Sawyer, J. and Al, E. (1998) "MDS-associated eytogenetic abnormalities in both hematopoietic and neoplastic cells after Watotrezspbrm in 868 patients with multiple myeloma". Blood 92, 398a.
   Google Scholar
• Ro.ssi, G., Pelizzari. A.M.. Beltran'. D.. Tonelli. M. and Barlati, S. 12000) "Cytugenetie analogy between myelodysplastic syndrome and acute myeloid leukemia or elderly patients", Leukemia 14, 636–641.
   PubMed Web of Science ®Google Scholar
• Le Bean Multiple MyelornaNeuman. W.L., Rios, R.13,. Larson. R.A., Rowley, JD.. Vardiman, LW.. Schwartz, J.L. and Farber, R.A. (1992i "Chromosomal loss and deletion are the most common mechanism for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders", Blood 79, 1501–1510.
   Google Scholar
• Sozzi. G.. Miozzo, M., Orazi, A.. Calderone, C.. Castellano, M.. Vivian', S., Santoro, A.. Pierotti. M.A. and Della Porta. G. (1990) "Cylogenetie study in therapy-related tnyelndysplastic syndromes (t-MDS) and acute non-lymphocylic leukaemia (t-ANLL)", Dr. J. Cancer 61. 425-.428.
   Google Scholar
• Nakamura, H., Sato, T., Watanabe. T.. Ikeda, S., Sadatnori. N. and Ichiroaru., M. (1989) "Chromosome 21 rearrangement in a case of therapy-related myelodysplastic syndrome in multiple myr.loma". Riosho Kersueki-Jpn. J. Clin. Helmand. 30. 216–221,
   Google Scholar
• Shimizu, S., Suzakiawa, K., Kodera, T.. Nags-sawn, T.. Abe, T., Taniwaki, M. Yagasaki. F. Tanaka, H., Fujisawa, S.. Johannson, B., Ahlgren. T., Yokota, J. and Morishita, K. (2000) "Identification of breakpoint cluster regions at 1p36.3 and 3421 in hematological malignancies with t(1;3)(p36:q21)". Genes Chtrunnsames Cancer 27, 229–238.
   PubMed Web of Science ®Google Scholar
• Yamamoto. K.. Nagata. K.. Tsurukubo, Y.. Morishim, K. and Hantaguchi, H. (2000) "A novel iranslocation t(3:22)(q211q11) involving 3q21 in myelodysplastic syndrome-derived overt leukemia with thrombecytosis", leak. Res. 24. 453–457.
   PubMed Web of Science ®Google Scholar
• Rasa. A.. Meyer, P. Dtitt, D., Zorat. E. Li sak. L, Nascimben, F.. du Randt. M.. !Caspar. C., Goldberg, C., Logw., 1., Dar, S., Gezer. S., Venugopal, P. and Zeldis, I. (2001) "Thalidomide produces transfusion independence in lung-standing refractory anemias of patients with myelodysplastic syndromes". Blood 98, 958–965.
   Google Scholar
• Singhal. S.. Mehtn, 3.. Desikan. R., Ayers. D.. Roberson, P.. Eddlemoia, P. Munshi, N., Anais.sie, E., Wilson. C.. Dhodapkar. M.. Zeldis, J. and Barlogie, B. (1999) "Antitumor activity of thalidomide in refractory multiple myeionm", N. Engl. J. Med. 341, 1565–1571.
   PubMed Web of Science ®Google Scholar
• Pcdersen-Bjergaard, J.. Anderson, M.K. and Christiansen, OH. (2000) 'Therapy-related acute myeloid leukemia and tnyelodys-plasma after high-dose chemotherapy and autologous Stem cell transplantation". Blood 95, 3273 3279.
   Google Scholar
• Fonseca. R., Hoyer, J.D., Aptly& P., Jabal. S.M.. Akinaan. 0.1., Rajkumar, S.V., Wilzig. T.E. Lacy, M.O.. Dispenzieri„ A.. Gertz, MA, Kyle. R.A. and (ireipp. P.R. (1999) "Clinical significance of rho iranslocation (11:14) (q32) in multiple enyelorre, Leak. Lymphoma 35, 599–605.
   PubMed Web of Science ®Google Scholar
• Tricot. G.. 13 arlogie, B.. Jagannath. S.. Bracy. D.. Mattox, S., Vesole. D.H., Naucke, S. and Sawyer. J.R. 1.1995) "Poor pmgnosis in multiple myeloma is associated only with partial or complete deletions of chromosomes 13 or abnormalities involving I lq and not with other karritype abnormalities". Blood 86, 4250 4256.
   Google Scholar
• Tricot, G.. Sawyer. I.R... Jagannath, S., Desikan, K.P... Siegel. D., Naucke. S., Manua. S.. Bracy, D., Munshi, N. and Biologie. 13. 11997) "Unique vole of tytogenetics in the prognosis of patients with myclunta receiving high-dose therapy and auttnransplants", J. ain. Oncul. 15. 2659–2666.
   Google Scholar
• Midler. A., Raattani, P.. Hardan. F.. Avigdor, A., Levi. 1., Berkowicz. M. and Ben-Bassat, 1. (2000) '"rhorapy with thalidomide in refractory multiple myeloma patients-the revival of au old drug", Br. J. Haematal. 108. 391–393.
   Google Scholar
• Zomas, A.. Anagnostopoulos, N. and Dintopoulos, M.A. (2000) "Successful treatment of multiple myclutnn relapsing after high, dose therapy and tautologous transplantation with thalidomide as a skive agent", Bone Marrow Transplant 25. 1319–1320.
   PubMed Web of Science ®Google Scholar
• Meg, 11.J., Beckham. C.. Loken, MIL, Bryant. E., Lesnikova. M.. Shulman, 11,M. and Cooley, T. (2000) "Negative regulators of heinopoicsis and gm function in patients with myelodysplastic syndrome", Leak. I ymphonra 37. 405–414.
   Google Scholar
• Davies, FE., Reje, N.. Ilideshitna. T.. Lentzsch, S., Young. G.. Tai. Y.-T.. Lin, B., Podar, K., Gupta, D., Chanhan„ D.. Treon, S.P., Richardson, P.O., Schlossman. R.L.. Morgan, G.J.. Muller. G.W.. Stirling, D.I. and Anderson. K.C. (2001) "Thalidomide and imrnunomodulatory derivatives augment natural killer cell cyto-toxicity in multiple mychania". Blood 98. 210 216.
   PubMed Web of Science ®Google Scholar